The Nature of the Heterozygous Trp53 Knockout Model for Identification of Mutagenic Carcinogens

Author： French John Storer Richard D. Donehower Lawrence A.

ISSN： 0192-6233

Source： Toxicologic Pathology, Vol.29, Iss.5, 2001-09, pp. : 24-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA Repair-Deficient Xpa and Xpa/p53^+/- Knock-Out Mice: Nature of the Models

By van Steeg Harry de Vries Annemieke van Oostrom Conny TH. M. Van Benthem Jan Beems Rudolf B. van Kreijl Coen F.

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 109-116

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Toxicity and Carcinogenicity Studies of Chlorpromazine Hydrochloride and p-Cresidine in the p53 Heterozygous Mouse Model

By Petruska Janet M. Frank Doyle W. Freeman Gary B. Evans Ellen W. MacDonald James S.

Toxicologic Pathology, Vol. 30, Iss. 6, 2002-11 ,pp. : 696-704

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens

By McDorman Kevin S. Wolf Douglas C.

Toxicologic Pathology, Vol. 30, Iss. 6, 2002-11 ,pp. : 675-680

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Xpa and Xpa/p53^+/- Knockout Mice: Overview of Available Data

By van Kreijl Coen F. McAnulty Peter A. Beems Rudolf B. Vynckier An van Steeg Harry Fransson-Steen Ronny Alden Carl L. Forster Roy van der Laan Jan-Willem Vandenberghe John

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 117-127

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Trp53 Hemizygous Mouse in Pharmaceutical Development: Points to Consider for Pathologists

By Floyd Eugenia Mann Peter Long Gerald Ochoa Ricardo

Toxicologic Pathology, Vol. 30, Iss. 1, 2002-01 ,pp. : 147-156

Ashgate Publishing Ltd

Access to resources Recommend Favorite